Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer's disease and Parkinson's disease.

Fang, Xin; Zhou, Xiaoting; Miao, Yuqing; Han, Yiwen; Wei, Jing; Chen, Tingtao

Fang, Xin; Zhou, Xiaoting; Miao, Yuqing; Han, Yiwen; Wei, Jing; Chen, Tingtao.

Afiliação

Fang X; Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhou X; Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Miao Y; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, 1299 Xuefu Road, Honggu District, Nanchang, 330031, Jiangxi, People's Republic of China.
Han Y; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, 1299 Xuefu Road, Honggu District, Nanchang, 330031, Jiangxi, People's Republic of China.
Wei J; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, 1299 Xuefu Road, Honggu District, Nanchang, 330031, Jiangxi, People's Republic of China.
Chen T; Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China. chentingtao1984@163.com.

AMB Express ; 10(1): 80, 2020 Apr 24.

Article em En | MEDLINE | ID: mdl-32333225

Palavras-chave

Alzheimer's disease (AD); Engineered bacteria; Glucagon-like peptide-1 (GLP-1); High-throughput sequencing; MG1363-pMG36e-GLP-1; Neuroinflammation; Parkinson's disease (PD)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: AMB Express Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google